186 related articles for article (PubMed ID: 12538468)
1. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of KIT expression in small cell lung cancer.
López-Martin A; Ballestín C; Garcia-Carbonero R; Castaño A; Lopez-Ríos F; López-Encuentra A; Sánchez-Cespedes M; Castellano D; Bartolomé A; Cortés-Funes H; Paz-Ares L
Lung Cancer; 2007 Jun; 56(3):405-13. PubMed ID: 17420067
[TBL] [Abstract][Full Text] [Related]
4. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
[TBL] [Abstract][Full Text] [Related]
6. Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications.
Camps C; Sirera R; Bremnes RM; Garde J; Safont MJ; Blasco A; Berrocal A; Sánchez JJ; Calabuig C; Martorell M
Lung Cancer; 2006 Jun; 52(3):343-7. PubMed ID: 16574270
[TBL] [Abstract][Full Text] [Related]
7. ErbB-3 predicts survival in ovarian cancer.
Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
[TBL] [Abstract][Full Text] [Related]
8. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
9. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis.
Naeem M; Dahiya M; Clark JI; Creech SD; Alkan S
Hum Pathol; 2002 Dec; 33(12):1182-7. PubMed ID: 12514786
[TBL] [Abstract][Full Text] [Related]
10. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
[TBL] [Abstract][Full Text] [Related]
11. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
Krystal GW; Hines SJ; Organ CP
Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
[TBL] [Abstract][Full Text] [Related]
13. Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L
Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
Oshita F; Kameda Y; Ikehara M; Tanaka G; Yamada K; Nomura I; Noda K; Shotsu A; Fujita A; Arai H; Ito H; Nakayama H; Mitsuda A
Anticancer Res; 2002; 22(2B):1065-70. PubMed ID: 12168902
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
Zhao P; Hou N; Shao Y; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
Chang MH; Lee J; Han J; Park YH; Ahn JS; Park K; Ahn MJ
APMIS; 2009 Dec; 117(12):861-9. PubMed ID: 20078550
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of imatinib in patients with small cell lung cancer.
Johnson BE; Fischer T; Fischer B; Dunlop D; Rischin D; Silberman S; Kowalski MO; Sayles D; Dimitrijevic S; Fletcher C; Hornick J; Salgia R; Le Chevalier T
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5880-7. PubMed ID: 14676110
[TBL] [Abstract][Full Text] [Related]
19. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N
Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
